Neogen Corp stock (US6404911066): Recent 1.95% gain amid volatility

Neogen Corp (NEOG) shares rose 1.95% to $5.22 on July 25, 2025, marking five straight days of gains, though forecasts point to potential declines ahead of earnings on July 29.

Neogen Corp stock climbed 1.95% on Friday, July 25, 2025, advancing from $5.12 to $5.22 on Nasdaq, according to StockInvest.us as of July 2025. The shares fluctuated 3.11% that day, hitting a low of $5.12 and a high of $5.28. This move extended a streak of five consecutive gains, despite a 3.15% loss over the prior two weeks.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Neogen Corporation
• Sector/industry: Diagnostics and specialty chemicals for food and animal safety
• Headquarters/country: United States
• Core markets: Food safety, animal health
• Key revenue drivers: Genomic testing, microbial detection products
• Home exchange/listing venue: Nasdaq (NEOG)
• Trading currency: USD

Neogen Corp: core business model

Neogen Corporation develops and markets diagnostic test kits and related products for the food safety and animal protein industries. The company operates through two main segments: Food Safety and Animal Safety. Food Safety focuses on testing solutions for contaminants like pathogens and toxins in food production, while Animal Safety provides tests for livestock diseases and veterinary diagnostics. These offerings help ensure compliance with regulatory standards in agriculture and food processing.

Headquartered in Lansing, Michigan, Neogen serves global markets but maintains significant exposure to the US agriculture sector, which is vital for American investors tracking biotech and agrotech plays. The company's genomic tools, including DNA testing for species identification, support breeders and processors in the US livestock industry.

Main revenue and product drivers for Neogen Corp

Key products include the ANSR system for rapid microbial detection and genomic tests like Neogen's Igenity portfolio for beef and dairy cattle genetics. Revenue is driven by sales to food processors, veterinarians, and agribusinesses. In recent trading, the stock reflected ongoing demand in these areas, with the July 25 price action showing resilience amid broader market volatility, per StockInvest.us as of July 2025.

Neogen's tools are particularly relevant for US investors given the scale of American meat production and food safety regulations enforced by the USDA and FDA. Upcoming earnings on July 29, 2025, are expected to show EPS of $0.0900, providing insights into segment performance.

Industry trends and competitive position

The animal health and food diagnostics market is growing due to rising demand for safe protein sources and precision agriculture. Neogen competes with players like Zoetis in animal diagnostics but differentiates through specialized food safety kits. US market exposure ties its fortunes to domestic farm output, which influences investor interest in ag-related stocks.

Why Neogen Corp matters for US investors

Listed on Nasdaq, Neogen offers US investors direct access to innovations in food and animal safety, sectors bolstered by American agricultural dominance. Recent price gains highlight potential amid volatility, with support levels at $5.08 noted in technical analysis.

Conclusion

Neogen Corp's recent 1.95% stock gain on July 25, 2025, underscores short-term momentum heading into earnings, though forecasts suggest caution with potential declines ahead. The company's role in US food and animal safety diagnostics provides steady relevance for investors monitoring agrotech. Market dynamics, including support levels and volatility, will shape near-term trading.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.